Related Experiment Video
Updated: Mar 8, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Post-procedural myocardial infarction following surgical aortic valve replacement and transcatheter aortic valve
Laura E Dobson1, Tarique A Musa, Akhlaque Uddin
1Multidisciplinary Cardiovascular Research Centre (MCRC) & Division of Biomedical Imaging, LICAMM, University of Leeds, Leeds, United Kingdom.
Insights
Myocardial infarction (MI) is less common after transcatheter aortic valve implantation (TAVI) than surgical aortic valve replacement (SAVR). Cardiovascular magnetic resonance imaging shows new MI occurs more frequently with SAVR, with small infarct sizes in both procedures.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Interventional Cardiology
Background:
- Myocardial injury is common after aortic valve replacement procedures, making it hard to distinguish focal myocardial infarction (MI) from global injury.
- Cardiac biomarker release is a standard but imprecise measure of myocardial injury post-SAVR and TAVI.
- Cardiovascular magnetic resonance (CMR) with late gadolinium enhancement (LGE) offers a more precise method to assess myocardial injury.
Purpose of the Study:
- To compare the rates of new myocardial infarction (MI) following surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI).
- To utilize Cardiovascular Magnetic Resonance (CMR) late gadolinium enhancement (LGE) imaging to quantify and compare myocardial injury between SAVR and TAVI.
- To evaluate the impact of new MI on left ventricular ejection fraction changes post-procedure.
Main Methods:
- Ninety-six patients (39 SAVR, 57 TAVI) underwent identical CMR scans at baseline and six months post-procedure.
- Cardiovascular magnetic resonance (CMR) with late gadolinium enhancement (LGE) was used to detect and quantify new myocardial infarction (MI).
- Patient data included procedural type, presence of coronary artery disease (CAD), and changes in left ventricular ejection fraction.
Main Results:
- The rate of new myocardial infarction (MI) was significantly higher following SAVR (26%) compared to TAVI (5%) (p=0.004).
- Infarct mass was similar between the groups, indicating small infarct sizes regardless of the procedure.
- New MI did not significantly impact the change in left ventricular ejection fraction in either the SAVR or TAVI groups.
Conclusions:
- Myocardial infarction (MI) is an infrequent complication of TAVI but more common after SAVR.
- The infarct size is small following both SAVR and TAVI.
- The low rate of new MI in TAVI patients, even with significant coronary artery disease, suggests pre-procedural revascularization may not always be necessary.
Aims:
Myocardial injury assessed using cardiac biomarker release is ubiquitous following surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI), preventing accurate discrimination between focal myocardial infarction (MI) and global injury. Cardiovascular magnetic resonance (CMR) late gadolinium enhancement (LGE) imaging was used to compare rates of new MI following SAVR and TAVI.
Methods And Results:
Identical CMR scans were obtained at baseline and six months post procedure in ninety-six patients undergoing SAVR (n=39) and TAVI (n=57). The rate of new MI was greater following SAVR than TAVI (SAVR, n=10 [26%] vs. TAVI, n=3 [5%], p=0.004). Infarct mass was similar between groups (SAVR 1.1±0.6 vs. TAVI 2.0±1.4 g, p=0.395). New MI did not impact on change in LV ejection fraction (SAVR:LGE[+]2.2±4.7 vs. LGE[-]0.9±8.0%, p=0.437, TAVI:LGE[+]-0.9±6.0 vs. LGE[-]2.0±7.8%, p=0.420). Thirty-four patients (60%) in the TAVI group had non-revascularised coronary artery disease (CAD) at the time of TAVI, of whom three (9%) had new MI.
Conclusions:
MI is an infrequent complication of TAVI but is more common following SAVR. Infarct size is small following both procedures. The low new infarct rate in TAVI, especially in the context of high rates of non-revascularised CAD, strengthens data from previous studies suggesting that coronary revascularisation pre-TAVI may be unnecessary.
Related Concept Videos
Aneurysm IV: Nursing Management
Aneurysm III: Interprofessional Care
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

